Dr Ing Valuation
| DRPRF Stock | USD 59.39 4.01 6.32% |
At this time, the firm appears to be overvalued. Dr Ing hc owns a latest Real Value of $51.69 per share. The recent price of the firm is $59.39. Our model computes the value of Dr Ing hc from reviewing the firm fundamentals such as Revenue of 36.76 B, operating margin of 0.20 %, and EBITDA of 9.38 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Dr Ing's price fluctuation is very steady at this time. Calculation of the real value of Dr Ing hc is based on 3 months time horizon. Increasing Dr Ing's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DRPRF pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Dr Ing hc. Since Dr Ing is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DRPRF Pink Sheet. However, Dr Ing's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 59.39 | Real 51.69 | Hype 59.39 | Naive 56.19 |
The real value of DRPRF Pink Sheet, also known as its intrinsic value, is the underlying worth of Dr Ing hc Company, which is reflected in its stock price. It is based on Dr Ing's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Dr Ing's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Dr Ing hc helps investors to forecast how DRPRF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dr Ing more accurately as focusing exclusively on Dr Ing's fundamentals will not take into account other important factors: Dr Ing Total Value Analysis
Dr Ing hc is currently projected to have takeover price of 0 with market capitalization of 0, debt of 9.75 B, and cash on hands of 5.87 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dr Ing fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 9.75 B | 5.87 B |
Dr Ing Investor Information
About 14.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Dr Ing hc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Dr Ing Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of DRPRF implies not a very effective usage of assets in February.Dr Ing Profitability Analysis
The company reported the revenue of 36.76 B. Net Income was 4.03 B with profit before overhead, payroll, taxes, and interest of 8.99 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Dr Ing's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Dr Ing and how it compares across the competition.
About Dr Ing Valuation
The pink sheet valuation mechanism determines Dr Ing's current worth on a weekly basis. Our valuation model uses a comparative analysis of Dr Ing. We calculate exposure to Dr Ing's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dr Ing's related companies.8 Steps to conduct Dr Ing's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Dr Ing's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Dr Ing's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Dr Ing's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Dr Ing's revenue streams: Identify Dr Ing's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Dr Ing's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Dr Ing's growth potential: Evaluate Dr Ing's management, business model, and growth potential.
- Determine Dr Ing's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Dr Ing's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Dr Ing Growth Indicators
Investing in growth stocks can be very risky. If the company such as Dr Ing does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | 9.1 B |
Complementary Tools for DRPRF Pink Sheet analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |